Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 14 (Search time: 0.001 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2019Right or left primary site of colorectal cancer: outcomes from the molecular analysis of the AGITG MAX TrialTapia Rico, G.; Price, T.; Tebbutt, N.; Hardingham, J.; Lee, C.; Buizen, L.; Wilson, K.; Gebski, V.; Townsend, A.
2015Detection and clinical significance of circulating tumor cells in colorectal cancer - 20 years of progressHardingham, J.; Grover, P.; Winter, M.; Hewett, P.; Price, T.; Thierry, B.
2014Nanostructured polystyrene well plates allow unbiased high-throughput characterization of circulating tumor cellsWan, Y.; Winter, M.; Delalat, B.; Hardingham, J.; Grover, P.; Wrin, J.; Voelcker, N.; Price, T.; Thierry, B.
2015Rising incidence of early-onset colorectal cancer in Australia over two decades: Report and reviewYoung, J.; Win, A.; Rosty, C.; Flight, I.; Roder, D.; Young, G.; Frank, O.; Suthers, G.; Hewett, P.; Ruszkiewicz, A.; Hauben, E.; Adelstein, B.; Parry, S.; Townsend, A.; Hardingham, J.; Price, T.
2014Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer researchGrover, P.; Cummins, A.; Price, T.; Roberts-Thomson, I.; Hardingham, J.
2013Prognostic impact and the relevance of PTEN copy number alterations in patients with advanced colorectal cancer (CRC) receiving bevacizumabPrice, T.; Hardingham, J.; Lee, C.; Townsend, A.; Wrin, J.; Wilson, K.; Weickhardt, A.; Simes, R.; Murone, C.; Tebbutt, N.
2015Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancerPrice, T.; Bruhn, M.; Lee, C.; Hardingham, J.; Townsend, A.; Mann, K.; Simes, J.; Weickhardt, A.; Wrin, J.; Wilson, K.; Gebski, V.; Van Hazel, G.; Robinson, B.; Cunningham, D.; Tebbutt, N.
2016Pharmacological blockade of aquaporin-1 water channel by AqB013 restricts migration and invasiveness of colon cancer cells and prevents endothelial tube formation in vitroDorward, H.; Du, A.; Bruhn, M.; Wrin, J.; Pei, J.; Evdokiou, A.; Price, T.; Yool, A.; Hardingham, J.
2013Can we accurately report PTEN status in advanced colorectal cancer?Price, T.; Hocking, C.; Broadbridge, V.; Wrin, J.; Townsend, A.R.; Tebbutt, N.; Cooper, J.; Ruszkiewicz, A.; Lee, C.; Hardingham, J.; 17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity (27 Sep 2013 - 1 Oct 2013 : Amsterdam, Netherlands)
2011Desmin expression in colorectal cancer stroma correlates with advanced stage disease and marks angiogenic microvesselsArentz, G.; Chataway, T.; Price, T.; Izwan, Z.; Hardi, G.; Cummins, A.; Hardingham, J.